Thomas Joeseph Carrico
Known title: CRO, CCO, CPOCIK: 0001959325
Thomas Joeseph Carrico's purchase track record
Thomas Joeseph Carrico has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/8/2026 | NRXS | $2K | pending | pending | — |
| 4/1/2026 | NRXS | $1K | -1.4% | +2.6% | +16.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NRXS | ▲ Buy | Open Market | 328 | $2K | 10/8/2026 | View on chart |
| NRXS | ▲ Buy | Grant | 193,678 | — | 8/24/2026 | View on chart |
| NRXS | ▲ Buy | Open Market | 667 | $1K | 4/1/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
NeurAxis Names Craig Blanchard CCO to Drive Commercial Growth
NeurAxis has appointed Craig Blanchard as chief commercial officer to lead the next phase of commercial growth. The move signals the company’s focus on expanding market reach and accelerating product commercialization. Blanchard’s experience is expected to help the firm move from development to broader market adoption.
NeurAxis Names Craig Blanchard CCO to Drive Commercial Growth. NeurAxis has appointed Craig Blanchard as chief commercial officer to lead the next phase of commercial growth. The move signals the company’s focus on expanding market reach and accelerating product commercialization. Blanchard’s experience is expected to help the firm move from development to broader market adoption.